- By Deborah Balzer
Mayo Clinic launches radio campaign to encourage recovered patients of COVID-19 to donate plasma
Mayo Clinic is collaborating with Entercom Communications to launch a radio campaign that raises awareness in Detroit, New York City, Miami and Chicago of the federally-sponsored national Expanded Access Program (EAP) for Convalescent Plasma. The Food and Drug Administration announced Mayo Clinic as the lead site for the EAP program to speed access and increase availability of investigational convalescent plasma for hospitalized patients in need. This is important work aiming to lessen severity of disease.
The radio campaign begins May 7 to let people who’ve recovered from COVID-19 know about the need for blood donations. Visit uscovidplasma.org and visit Mayo Clinic’s Facebook, Twitter, LinkedIn, YouTube and Instagram accounts to see our social media posts and help us share the message. The American Red Cross and the larger blood-banking community, which works with physicians to collect and distribute the donor plasma, support the national program.
The need is great, the time is now. In just one month, 4,800 physicians at more than 2,100 hospitals and acute care facilities have registered and enrolled more than 11,000 patients. More than 6,600 patients have received an infusion, the numbers grow every day.
Physicians at any institution in the United States who are treating hospitalized patients with COVID-19 can register their patients’ information at uscovidplasma.org.
Led by researcher Michael Joyner, M.D., the EAP for Convalescent Plasma grew from a national initiative of physicians and investigators from 40 institutions who self-organized to investigate the use of convalescent plasma during the COVID-19 pandemic. These institutions include Mayo Clinic, Johns Hopkins University, Washington University, Einstein Medical Center, Icahn School of Medicine at Mount Sinai, Michigan State University, as well as countless other academic medical centers and government agencies seeking to establish a national convalescent plasma program to modify the course of disease.
Mayo Clinic is committed to advancing the science of medicine to ensure patients are able to benefit from new discoveries as quickly as possible. Mayo’s goal is to rapidly discover and apply scientific advances that will defeat this deadly disease.
For the latest updates on the COVID-19 pandemic, check the Centers for Disease Control and Prevention website. For more information and COVID-19 coverage, go to the Mayo Clinic News Network and mayoclinic.org.